DANON DISEASE DIAGNOSIS BY TARGETED NEXT-GENERATION SEQUENCING: IDENTIFICATION OF LAMP2 MUTATIONS

The case report of the Danon disease firstly diagnosed in Belarus is presented. The targeted Next-Generation Sequencing (tNGS) was used to search for mutations in 46 genes associated with cardiomyopathy of different genesis in a patient suffered from dilated cardiomyopathy, peripheral muscle disorders and mild dementia. Hemizygous deletion c.864+3_864+6delGAGT (rs397516751, NM_002294.2) in the LAMP2 gene affecting the natural splice site was detected. The LAMP2 gene (Lysosomal Associated Membrane Protein 2, Xq24) encodes a membrane glycoprotein essential for the adhesion of lysosomes. Mutations in LAMP2 lead to the distortion of the autophagy by lysosomes and glycogen accumulation in the cells. Clinically, they manifest in the Danon disease: hypertrophic or dilated cardiomyopathy, skeletal myopathy, and mental retardation. The metabolic reason of cardiomyopathy has not been recognized in the present case. The tNGS has allowed one to correct the diagnosis. The early exact diagnosis for such patients is essential to slow down the disease progression. The Danon disease can proceed asymptomatically before puberty and then develops rapidly with sudden mortality. 

1. Charron P., Villard E., Sébillon P., Laforêt P., Maisonobe T., Duboscq-Bidot L., Romero N., Drouin-Garraud V., Frébourg T., Richard P., Eymard B., Komajda M. Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey. Heart, 2004, vol. 90, no. 8, pp. 842–846. doi.org/10.1136/hrt.2003.029504

2. Boucek D., Jirikowic J., Taylor M. Natural history of Danon disease. Genetics in Medicine, 2011, vol. 13, no. 6, pp. 563–568. doi.org/10.1097/gim.0b013e31820ad795

3. Danon M. J., Oh S. J., DiMauro S., Manaligod J. R., Eastwood A., Naidu S., Schliselfeld L. H. Lysosomal glycogen storage disease with normal acid maltase. Neurology, 1981, vol. 31, no. 1, pp. 51–57. doi.org/10.1212/wnl.31.1.51

4. Tanaka Y., Guhde G., Suter A., Eskelinen E.-L., Hartmann D., Lüllmann-Rauch R., Janssen P. M. L., Blanz J., von Figura K., Saftig P. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature, 2000, vol. 406, no. 6798, pp. 902–906. doi.org/10.1038/35022595

5. Sugie K., Yamamoto A., Murayama K., Oh S. J., Takahashi M., Mora M., Riggs J. E., Colomer J., Iturriaga C., Meloni A., Lamperti C., Saitoh S., Byrne E., DiMauro S., Nonaka I., Hirano M., Nishino I. Clinicopathological features of genetically confirmed Danon disease. Neurology, 2002, vol. 58, no. 12, pp. 1773–1778. doi.org/10.1212/wnl.58.12.1773

6. Maron B. J., Roberts W. C., Arad M., Haas T. S., Spirito P., Wright G. B., Almquist A. K., Baffa J. M., Saul J. P., Ho C. Y., Seidman J., Seidman C. E. Clinical Outcome and Phenotypic Expression in LANP2 Cardiomyopathy. JAMA, 2009, vol. 301, no. 12, pp. 1253–1259. doi.org/10.1001/jama.2009.371

7. Nishino I., Fu J., Tanji K., Yamada T., Shimojo S., Koori T., Mora M., Riggs J. E., Oh S. J., Koga Y., Sue C. M., Yamamoto A., Murakami N., Shanske S., Byrne E., Bonilla E., Nonaka I., DiMauro S., Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature, 2000, vol. 406, no. 6798, pp. 906–910. doi. org/10.1038/35022604

8. Bottillo I., Giordano C., Cerbelli B., D’Angelantonio D., Lipari M., Polidori T., Majore S., Bertini E., D’Amico A., Giannarelli D., de Bernardo C., Masuelli L., Musumeci F., Avella A., Re F., Zachara E., d’Amati G., Grammatico P. A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review. Cardiovascular Pathology, 2016, vol. 25, no. 5, pp. 423–431. doi.org/10.1016/j.carpath.2016.07.005

9. NCBI/Primer-BLAST. Available at: http://www.ncbi.nlm.nih.gov/tools/primer-blast (accessed 15 December 2016).

10. FASTQC. Available at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ (accessed 20 January 2017).

11. IGV. Avaliable at: http://software.broadinstitute.org/software/igv/home (accessed 20 January 2017).

12. BWA. Available at: https://sourceforge.net/projects/bio-bwa/ (accessed 21 January 2017).

13. SAMtool v.1.18. Available at: http://samtools.sourceforge.net/ (accessed 22 January 2017).

14. GATK v3.2/2. Available at: https://www.broadinstitute.org/gatk/index.php (accessed 22 January 2017).

15. ANNOVAR. Available at: http://annovar.openbioinformatics.org/en/latest/ (accessed 25 January 2017).

16. ClinVar. Available at: https://www.ncbi.nlm.nih.gov/clinvar/ (accessed 1 February 2017).

17. HSF. Available at: http://www.umd.be/HSF3/HSF.html (accessed 1 February 2017).

18. MaxEntScan. Available at: http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html (accessed 1 February 2017).

19. NetGene2. Available at: http://www.cbs.dtu.dk/services/NetGene2/ (accessed 1 February 2017).

20. NNSPlice. Available at: http://www.fruitfly.org/seq_tools/splice.html (accessed 1 February 2017).

21. SplicePort. Available at: http://spliceport.cbcb.umd.edu/ (accessed 1 February 2017).

22. OMIM. Available at: https://www.omim.org/ (accessed 1 February 2017).

23. Cetin H., Wöhrer A., Rittelmeyer I., Gencik M., Zulehner G., Zimprich F., Ströbel T., Zimprich A. The c.65-2A/G splice site mutation is associated with a mild phenotype in Danon disease due to the transcription of normal LAMP2 mRNA. Clinical Genetics, 2016, vol. 90, no. 4, pp. 366–371. doi.org/10.1111/cge.12724